CRISPR Benefits Available in This Genomics ETF

The fight against the novel coronavirus is putting plenty of healthcare ETFs in the spotlight this year, including the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG), but there’s much more to the ARKG story. In fact, ARKG was one of the best-performing healthcare ETFs prior to COVID-19...